July 2016 |
|
Wyden Statement on New USTR Case Targeting Chinese Trade Restrictions
|
|
Wyden Introduces Bill To Help First Time Homebuyers
|
|
Wyden Floor Statement on Opioid Bill and Mary Wakefield Nomination
|
|
Wyden Statement at Finance Committee Hearing on MACRA
|
|
Wyden Statement on Approval of EU-U.S. Privacy Shield Framework
|
|
Wyden Statement at Finance Committee Hearing on Stark Law
|
|
Wyden Comments on 385 Regulations Following Meeting with Treasury Secretary Lew
|
|
Wyden Disappointed in Multi-Million Dollar Windfall for Drug Makers Instead of Care for Pregnant Women in Opioid Conference Report
|
|
Wyden Concerned by National Academy Committee Ties to Opioid Manufacturers
|
June 2016 |
|
Wyden Statement at Finance Committee Hearing on Medicare Part B Drug Demonstration Project
|
|
Wyden Applauds Win for Trade Enforcement in ITC Steel Decisions
|
|
Wyden Comments on House GOP’s Tax Blueprint
|
|
Wyden Continues Fight Against Opioid Addiction, Calls for Greater Transparency of Pain Panel Ties to Pharmaceutical Industry
|
|
Wyden Statement on the Social Security and Medicare Trustees’ Reports
|
|
Finance Senators Introduce Family First Prevention Services Act
|
|
Wyden Asks DEA for Information on Surge of Illegally-Produced Fentanyl
|
|
Wyden Statement at Finance Committee Hearing on Trade in the Digital Economy
|
|
Wyden Statement at Brookings Institution on Chronic Care and Updating the Medicare Guarantee
|
|
Wyden, Brown Call Meeting With Administration to Press for Strong Enforcement of Anti-Slave Labor Provision
|
|
Wyden Hearing Statement on Energy Tax Policy
|